Active Ingredient(s): Irinotecan Liposome
FDA Approved: * October 22, 2015
Category: Cancer

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Onivyde Overview

Irinotecan, sold under the brand name Camptosar among others, is a medication used to treat colon cancer, and small cell lung cancer.[4] For colon cancer it is used either alone or with fluorouracil.[4] For small cell lung cancer it is used with cisplatin.[4] It is given intravenously.[4] Common side effects include diarrhea, vomiting, bone marrow suppression, hair loss, shortness of breath, and fever.[4] Other se...

Read more Onivyde Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Irinotecan

Recent Onivyde Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Irinotecan Liposome
  • Injection: 100mg/5ml (20mg/ml), 20mg/ml, 300mg/15ml (20mg/ml), 40mg/2ml (20mg/ml)
  • Injection, Liposomal: 43mg/10ml (4.3mg/ml)
  • Vial: 43mg/10ml
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Onivyde: (2 results)

Sorted by National Drug Code
  • 15054-0043 Onivyde 4.3 mg/ml Intravenous Injection, Powder, for Solution by Ipsen Biopharmaceuticals, Inc.
  • 69171-398 Onivyde 4.3 mg/ml Intravenous Injection by Merrimack Pharmaceuticals

Other drugs which contain Irinotecan Liposome or a similar ingredient: (2 results)